BAXTER INTERNATIONAL INC | 56,31 Euro | -0,05 -0,09 % | |
| WKN: 853815 ISIN: US0718131099 Ticker-Symbol: BTL | Stuttgart | 22.05.13 | 08:01 Uhr |
Branche GesundheitswesenAktienmarkt S&P 100S&P 500 |
|
|
| Zeit | Aktuelle Nachrichten
Sprache: | Leser | Medien | |
|---|---|---|---|---|
| 21.05. | Baxter Receives Marketing Authorization for HyQvia in European Union | 50 | Business Wire | |
| Baxter International Inc. (NYSE:BAX) and Halozyme Therapeutics, Inc., (NASDAQ:HALO) today announced that the European Commission has granted Baxter marketing authorization in all European... Mehr lesen zu: Baxter Receives Marketing Authorization for HyQvia in European Union | ||||
| 21.05. | Baxter International is Among the Companies in the Health Care Equipment Industry With the Lowest EPS Growth | 1 | SmarTrend | |
| 19.05. | Baxter International has the Highest Dividend Yield in the Health Care Equipment Industry | 5 | SmarTrend | |
| 16.05. | "Baxter" - Lachen ja, aber bitte mit Spotlight / Live-Action-Comedy im Rampenlicht ab 20. Mai bei KiKA | 66 | news aktuell | |
| Erfurt (ots) - In der einzigartigen, energiegeladenen Welt der Northern Star Schule für darstellende Künste kommt man nur weiter, wenn man in der ersten Reihe tanzt. Auffallen um jeden Preis, heißt... Mehr lesen zu: "Baxter" - Lachen ja, aber bitte mit Spotlight / Live-Action-Comedy im Rampenlicht ab 20. Mai bei KiKA | ||||
| 14.05. | Shares of Baxter International Rank the Highest in Terms of Return on Equity in the Health Care Equipment Industry | 6 | SmarTrend | |
| 08.05. | Baxter International Inc. - Shareholder/Analyst Call | 11 | Seeking Alpha | |
| 07.05. | Baxter International Set to Possibly Rebound After Yesterday's Selloff of 2.50% | 5 | SmarTrend | |
| 07.05. | Look for Shares of Baxter International to Potentially Rebound after Yesterday's 2.50% Sell Off | 3 | SmarTrend | |
| 07.05. | Baxter Alzheimer's treatment fails late-stage study | 4 | Irish Times | |
| 07.05. | Baxter Alzheimer's drug fails in late-stage study | 3 | bizjournals | |
| 07.05. | Barclays stuft Baxter von Equal Weight auf Overweight. | 108 | BörseGo | |
| Barclays stuft Baxter von Equal Weight auf Overweight.
(© BörseGo AG 2013 - Autor: Simon Hauser, Redakteur) Mehr lesen zu: Barclays stuft Baxter von Equal Weight auf Overweight. | ||||
| 07.05. | Baxter International Declining With Trend-Confirming Volume | 4 | SmarTrend | |
| 07.05. | UPDATE 1-Baxter's Alzheimer's disease drug fails in late-stage trial | 2 | Reuters.com | |
| 07.05. | Baxter's Potential Alzheimer's Treatment Immunoglobulin Misses Primary Endpoints | 3 | Euroinvestor | |
| 07.05. | BRIEF-Baxter shares down after drug fails in late-stage trial | 3 | Reuters.com | |
| 07.05. | Failure Of Baxter's Trial Another Blow To Alzheimer's Treatment | 3 | Forbes | |
| 07.05. | Baxter's Alzheimer's disease drug fails in late-stage trial | 3 | Reuters.com | |
| 07.05. | Baxter's Phase 3 Trial Of Immunoglobulin Fails To Meet Co-primary Endpoints | 46 | AFX News | |
| DEERFIELD (dpa-AFX) - Baxter International Inc. (BAX) Tuesday said its Phase
III clinical study of immunoglobulin or IG did not meet its co-primary endpoints
of reducing cognitive decline... Mehr lesen zu: Baxter's Phase 3 Trial Of Immunoglobulin Fails To Meet Co-primary Endpoints | ||||
| 07.05. | Baxter Immunoglobulin Fails to Aid Alzheimer's Patients | 3 | Bloomberg | |
| 07.05. | Baxter Announces Topline Results of Phase III Study of Immunoglobulin for Alzheimer's Disease | 3 | Benzinga.com | |
| Unternehmen / Aktien | Aktienkurs | % | Top-Nachrichten |
|---|---|---|---|
| FRESENIUS MEDICAL CARE | 53,09 | -0,17 % | XFRA DIVIDEND INFORMATION - 17.05.2013 - 1 |
| BIOTEST | 55,89 | -0,20 % | DGAP-DD: Biotest AG (deutsch) |
| RHOEN-KLINIKUM | 16,685 | -0,66 % | Im Fokus: Rhön-Klinikum AG |
| MEDTRONIC | 40,323 | +0,09 % | Medtronic übertrifft Umsatz- und Gewinnprognosen |
| BOSTON SCIENTIFIC | 7,075 | -0,48 % | Boston Scientific Long Term Data Demonstrate Bronchial Thermoplasty Treatment Benefits Persist Out to Five Years in Patients with Severe Asthma |
